Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Beta Bionics (BBNX) Consolidated Net Income (2024 - 2025)

Beta Bionics (BBNX) has disclosed Consolidated Net Income for 2 consecutive years, with -$13.5 million as the latest value for Q4 2025.

  • Quarterly Consolidated Net Income fell 11.42% to -$13.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$60.7 million through Dec 2025, down 46.94% year-over-year, with the annual reading at -$60.7 million for FY2025, 46.94% down from the prior year.
  • Consolidated Net Income hit -$13.5 million in Q4 2025 for Beta Bionics, up from -$14.2 million in the prior quarter.
  • In the past five years, Consolidated Net Income ranged from a high of -$8.3 million in Q1 2024 to a low of -$16.9 million in Q2 2025.